Controversies on how diabetes is diagnosed

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 2, 2012, Pages 97-103

  Malkani, Samir ^a   DeSilva, Taniya ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

autoimmune diabetes; diabetes mellitus; gestational diabetes; glucose tolerance test; hemoglobin A1C; MODY

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ACUTE DISEASE; ANTIBODY DETECTION; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC VALUE; DIET RESTRICTION; DIFFERENTIAL DIAGNOSIS; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; REPRODUCIBILITY; REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; GENETIC TESTING; GLUCOSE TOLERANCE TEST; GUIDELINES AS TOPIC; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; PREDIABETIC STATE; PREGNANCY; REPRODUCIBILITY OF RESULTS;

EID: 84858277375     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32835168c0     Document Type: Review

References (88)

1. Castorino K, Jovanovic L. Pregnancy and diabetes management: advances and controversies. Clin Chem 2011; 57:221-230. A review weighing the advantages and disadvantages of universal screening for GDM.
2. Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care 2011; 34 (Suppl. 2):S184-S190.
3. Lapolla A, Mosca A, Fedele D. The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: still a long way to go. Nutr Metab Cardiovasc Dis 2011; 21:467-475.
4. WHO. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Switzerland: WHO Publication. WHO Press; 2011. This article has a link to comprehensive review on this topic at http://www.who.int/topics/diabetes- mellitus/en/.
5. Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007; 167:1545-1551. (Pubitemid 47124186)
6. Sacks DB. A1C versus glucose testing: a comparison. Diabetes Care 2011; 34:518-523. Technical aspects of A1C and plasma glucose testing are reviewed in this article.
7. Rohlfing C, Wiedmeyer HM, Little R, et al. Biological variation of glycohemoglobin. Clin Chem 2002; 48:1116-1118. (Pubitemid 34680915)
8. Van 't Riet E, Alssema M, Rijkelijkhuizen JM, et al. Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care 2010; 33:61-66. This study examines the correlation of A1C with plasma glucose in general population and those with diabetes.
9. Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract 2010; 87:415-421.
10. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010; 152:770-777.
11. Pani LN, Korenda L, Meigs JB, et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008; 31:1991-1996.
12. Weykamp CW, Mosca A, Gillery P, Panteghini M. The analytical goals for hemoglobin A1c measurement in IFCC units and national glycohemoglobin standardization program units are different. Clin Chem 2011; 57:1204-1206.
13. Resnick HE, Harris MI, Brock DB, Harris TB. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2000; 23:176-180. (Pubitemid 30071020)
14. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1998; 317:371-375.
15. Nakagami T, Qiao Q, Tuomilehto J, et al. The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype. Diabetes Res Clin Pract 2002; 55:35-43. (Pubitemid 34033587)
16. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010; 33:562-568.
17. Lorenzo C, Haffner SM. Performance characteristics of the new definition of diabetes: the insulin resistance atherosclerosis study. Diabetes Care 2010; 33:335-337.
18. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 2007; 24:333-343. (Pubitemid 46452406)
19. Vable AM, Drum ML, Tang H, et al. Implications of the new definition of diabetes for health disparities. J Natl Med Assoc 2011; 103:219-223.
20. Carson AP, Reynolds K, Fonseca VA, Muntner P. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 2010; 33:95-97.
21. Pinelli NR, Jantz AS, Martin ET, Jaber LA. Sensitivity and specificity of glycated hemoglobin as a diagnostic test for diabetes and prediabetes in Arabs. J Clin Endocrinol Metab 2011; 96:1680-1683.
22. Choi SH, Kim TH, Lim S, et al. Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care 2011; 34:944-949.
23. Getaneh A, Andres R, Brillon DJ, Findley SE. Hemoglobin A(c) criterion for diabetes diagnosis among Hispanic and non-Hispanic populations. Endocr Pract 2011; 17:210-217.
24. Wilson DM, Kollman. Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors. Diabetes Care 2008; 31:381-385.
25. Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008; 31:1473-1478.
26. Saukkonen T, Cederberg H, Jokelainen J, et al. Limited overlap between intermediate hyperglycemia as defined by A1C5.7-6.4%, impaired fasting glucose, and impaired glucose tolerance. Diabetes Care 2011; 34:2314-2316.
27. McCance DR, Hanson RL, Charles MA, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994; 308:1323-1328.
28. Wong TY, Liew G, Tapp RJ, et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008; 371:736-743. (Pubitemid 351288874)
29. Colagiuri S, Lee CM, Wong TY, et al. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 2011; 34:145-150. A very large pooled database examining the relationship between retinopathy, A1C and plasma glucose.
30. Cheng YJ, Gregg EW, Geiss LS, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: implications for diabetes diagnostic thresholds. Diabetes Care 2009; 32:2027-2032.
31. Massin P, Lange C, Tichet J, et al. Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study. Arch Ophthalmol 2011; 129:188-195. A prospective study which attempts to identify the A1C and FPG that predict retinopathy development at 10 years.
32. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999; 354:617-621.
33. Qiao Q, Pyorala K, Pyorala M, et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 2002; 23:1267-1275. (Pubitemid 35238508)
34. Bartnik M, Ryden L, Malmberg K, et al. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Heart 2007; 93:72-77. (Pubitemid 46094058)
35. Ning F, Tuomilehto J, Pyorala K, et al. Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range. Diabetes Care 2010; 33:2211-2216.
36. Cederberg H, Saukkonen T, Laakso M, et al. Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study. Diabetes Care 2010; 33:2077-2083.
37. Paynter NP, Mazer NA, Pradhan AD, et al. Cardiovascular risk prediction in diabetic men and women using hemoglobin A1c vs diabetes as a high-risk equivalent. Arch Intern Med 2011; 171:1718-1720.
38. Cicek G, Uyarel H, Ergelen M, et al. Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis 2011; 22:131-137.
39. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010; 362:800-811. A community-based study which showed higher A1C was more strongly associated with cardiovascular risk and mortality than FPG.
40. Doerr R, Hoffmann U, Otter W, et al. Oral glucose tolerance test and HbA(1c) for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study. Diabetologia 2011; 54:2923-2930.
41. Huang Y, Bi Y, Wang W, et al. Glycated hemoglobin A1c, fasting plasma glucose, and two-hour postchallenge plasma glucose levels in relation to carotid intima-media thickness in Chinese with normal glucose tolerance. J Clin Endocrinol Metab 2011; 96:1461-1465.
42. Cavalot F, Pagliarino A, Valle M, et al. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the san luigi gonzaga diabetes study. Diabetes Care 2011; 34:2237-2243.
43. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and prediabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009; 32:287-294.
44. Anderwald C, Gastaldelli A, Tura A, et al. Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. J Clin Endocrinol Metab 2011; 96:515-524. The first study demonstrating sex differences in rates of glucose absorption in the gut.
45. Pavlakis M. Live kidney donation: a 36-year-old woman hoping to donate a kidney to her mother. JAMA 2011; 305:592-599.
46. Martinez-Hervas S, Argente C, Garcia-Jodar J, et al. Misclassification of subjects with insulin resistance and associated cardiovascular risk factors by homeostasis model assessment index. Utility of a postprandial method based on oral glucose tolerance test. Metabolism 2011; 60:740-746.
47. Bartoli E, Fra GP, Carnevale Schianca GP. The oral glucose tolerance test (OGTT) revisited. Eur J Intern Med 2011; 22:8-12.
48. Colagiuri S. Mismatch between diabetes diagnosis in primary care and recommended diagnostic criteria. Diabetes Res Clin Pract 2011; 91:263-264.
49. Selvin E, Steffes MW, Gregg E, et al. Performance of A1C for the classification and prediction of diabetes. Diabetes Care 2011; 34:84-89.
50. Abdul-Ghani MA, Abdul-Ghani T, Muller G, et al. Role of glycated hemoglobin in the prediction of future risk of T2DM. J Clin Endocrinol Metab 2011; 96:2596-2600.
51. Valdes S, Botas P, Delgado E, et al. HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h postchallenge plasma glucose: the Asturias study (1998-2005). Diabetes Metab 2011; 37:27-32.
52. Wang W, Lee ET, Howard BV, et al. Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study. Diabetes Care 2011; 34:363-368.
53. Fajans SS, Herman WH, Oral EA. Insufficient sensitivity of hemoglobin A(C) determination in diagnosis or screening of early diabetic states. Metabolism 2011; 60:86-91.
54. Malkani S, Mordes JP. Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med 2011; 124:395-401.
55. Herman WH, Fajans SS. Hemoglobin A1c for the diagnosis of diabetes: practical considerations. Pol Arch Med Wewn 2010; 120:37-40.
56. Cavagnolli G, Comerlato J, Comerlato C, et al. HbA(1c) measurement for the diagnosis of diabetes: is it enough? Diabet Med 2011; 28:31-35.
57. Dodd JM, Crowther CA, Antoniou G, et al. Screening for gestational diabetes: the effect of varying blood glucose definitions in the prediction of adverse maternal and infant health outcomes. Aust N Z J Obstet Gynaecol 2007; 47:307-312. (Pubitemid 47079558)
58. Gestational diabetes mellitus. Diabetes Care 2004; 27(Suppl. 1):S88-S90.
59. Hillier TA, Vesco KK, Pedula KL, et al. Screening for gestational diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 148:766-775. (Pubitemid 351717423)
60. Nolan CJ. Controversies in gestational diabetes. Best Pract Res Clin Obstet Gynaecol 2011; 25:37-49. This review provides an analysis of implications of the IADPSG recommendations and the timing of diagnosis of GDM.
61. Plasencia W, Garcia R, Pereira S, et al. Criteria for screening and diagnosis of gestational diabetes mellitus in the first trimester of pregnancy. Fetal Diagn Ther 2011; 30:108-115. A study that provides criteria for the glucose challenge test and glucose tolerance test for diagnosis of GDM in the first trimester.
62. Ferrara A, Weiss NS, Hedderson MM, et al. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia 2007; 50:298-306.
63. Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33:676-682.
64. Sacks DA, Greenspoon JS, Abu-Fadil S, et al. Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy. Am J Obstet Gynecol 1995; 172:607-614.
65. The HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58:453-459.
66. The American Diabetes Association. Position Statement: standards of medical care in diabetes - 2011. Diabetes Care 2011; 34(Suppl. 1):S12-S61.
67. Long H. Diagnosing gestational diabetes: can expert opinions replace scientific evidence? Diabetologia 2011; 54:2211-2213.
68. Blackwell SC. Staying with old guidelines. Am J Obstet Gynecol 2011; 204:371-372.
69. Jimenez-Navarro MF, Garcia-Pinilla JM, Garrido-Sanchez L, et al. Poor reproducibility of the oral glucose tolerance test in the diagnosis of diabetes during percutaneous coronary intervention. Int J Cardiol 2010; 142:245-249.
70. Ilany J, Michael L, Cohen O, et al. Glucose homeostasis abnormalities assessed by an OGTT in coronary artery disease patients during admission and follow-up at ambulation. Exp Clin Endocrinol Diabetes 2011; 119:463-466.
71. Greci LS, Kailasam M, Malkani S, et al. Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care 2003; 26:1064-1068. (Pubitemid 36929249)
72. Silverman RA, Thakker U, Ellman T, et al. Hemoglobin A1c as a screen for previously undiagnosed prediabetes and diabetes in an acute-care setting. Diabetes Care 2011; 34:1908-1912.
73. Mazurek JA, Hailpern SM, Goring T, Nordin C. Prevalence of hemoglobin A1c greater than 6.5% and 7.0% among hospitalized patients without known diagnosis of diabetes at an urban inner city hospital. J Clin Endocrinol Metab 2010; 95:1344-1348.
74. Turner R, Stratton I, Horton V, et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997; 350:1288-1293. (Pubitemid 28036638)
75. Grant SF, Hakonarson H, Schwartz S. Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults? Endocr Rev 2010; 31:183-193.
76. Rolandsson O, Palmer JP. Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes! Diabetologia 2010; 53:1250-1253.
77. Hillman M, Torn C, Landin-Olsson M. The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset. Clin Exp Immunol 2009; 157:255-260.
78. Andersen MK, Lundgren V, Turunen JA, et al. Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years. Diabetes Care 2010; 33:2062-2064. This study shows genetic heterogenity and GAD antibody differences within those with LADA.
79. Bingley PJ. Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab 2010; 95:25-33.
80. Brophy S, Brunt H, Davies H, et al. Interventions for latent autoimmune diabetes (LADA) in adults [online]. Cochrane Database Syst Rev 2011 Issue 9. Art. No.: CD006165. A comprehensive systematic review on outcomes of interventions for LADA, shows paucity of data.
81. Klingensmith GJ, Pyle L, Arslanian S, et al. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care 2010; 33:1970-1975.
82. Balasubramanyam A, Nalini R, Hampe CS, Maldonado M. Syndromes of ketosis-prone diabetes mellitus. Endocr Rev 2008; 29:292-302. (Pubitemid 351679700)
83. Wucher H, Lepercq J, Timsit J. Onset of autoimmune type 1 diabetes during pregnancy: prevalence and outcomes. Best Pract Res Clin Endocrinol Metab 2010; 24:617-624.
84. Shepherd M. Stopping insulin injections following genetic testing in diabetes: impact on identity. Diabet Med 2010; 27:838-843.
85. Naylor R, Philipson LH. Who should have genetic testing for maturity-onset diabetes of the young? Clin Endocrinol 2011; 75:422-426. A comprehensive review on phenotypic and genetic relationships in MODY subtypes.
86. Incani M, Cambuli VM, Cavalot F, et al. Clinical application of best practice guidelines for the genetic diagnosis of MODY2 and MODY3. Diabet Med 2010; 27:1331-1333.
87. Twombly JG, Long Q, Zhu M, et al. Validity of the primary care diagnosis of diabetes in veterans in the southeastern United States. Diabetes Res Clin Pract 2011; 91:395-400.
88. Ogunyemi DA, Fong A, Rad S, et al. Attitudes and practices of healthcare providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG). Diabet Med 2011; 28:976-986.